119 related articles for article (PubMed ID: 12658071)
1. Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).
Chausmer AL; Smith BJ; Kelly RY; Griffiths RR
Behav Pharmacol; 2003 Mar; 14(2):111-20. PubMed ID: 12658071
[TBL] [Abstract][Full Text] [Related]
2. Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.
Nann-Vernotica E; Donny EC; Bigelow GE; Walsh SL
Psychopharmacology (Berl); 2001 Jun; 155(4):338-47. PubMed ID: 11441423
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166).
Romach MK; Glue P; Kampman K; Kaplan HL; Somer GR; Poole S; Clarke L; Coffin V; Cornish J; O'Brien CP; Sellers EM
Arch Gen Psychiatry; 1999 Dec; 56(12):1101-6. PubMed ID: 10591286
[TBL] [Abstract][Full Text] [Related]
4. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.
Jones HE; Garrett BE; Griffiths RR
J Pharmacol Exp Ther; 1999 Jan; 288(1):188-97. PubMed ID: 9862770
[TBL] [Abstract][Full Text] [Related]
5. Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans.
Haney M; Ward AS; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2001 Jun; 155(4):330-7. PubMed ID: 11441422
[TBL] [Abstract][Full Text] [Related]
6. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
Garrett BE; Griffiths RR
J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
[TBL] [Abstract][Full Text] [Related]
7. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
Jones HE; Griffiths RR
Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
[TBL] [Abstract][Full Text] [Related]
8. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
Sobel BF; Sigmon SC; Griffiths RR
Neuropsychopharmacology; 2004 May; 29(5):991-1003. PubMed ID: 15010695
[TBL] [Abstract][Full Text] [Related]
9. The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study.
Pirtle JL; Hickman MD; Boinpelly VC; Surineni K; Thakur HK; Grasing KW
Pharmacol Biochem Behav; 2019 May; 180():52-59. PubMed ID: 30811963
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine.
Johnson MW; Strain EC; Griffiths RR
Exp Clin Psychopharmacol; 2010 Aug; 18(4):305-15. PubMed ID: 20695686
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and physiological effects of cocaine in humans following triazolam.
Haga JL; Baker RW; Rush CR
Pharmacol Biochem Behav; 2003 Dec; 76(3-4):383-92. PubMed ID: 14643836
[TBL] [Abstract][Full Text] [Related]
12. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.
Reissig CJ; Carter LP; Johnson MW; Mintzer MZ; Klinedinst MA; Griffiths RR
Psychopharmacology (Berl); 2012 Sep; 223(1):1-15. PubMed ID: 22526529
[TBL] [Abstract][Full Text] [Related]
13. Physiological, subjective and reinforcing effects of oral and intravenous cocaine in humans.
Smith BJ; Jones HE; Griffiths RR
Psychopharmacology (Berl); 2001 Aug; 156(4):435-44. PubMed ID: 11498721
[TBL] [Abstract][Full Text] [Related]
14. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
Neisewander JL; O'Dell LE; Redmond JC
Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
[TBL] [Abstract][Full Text] [Related]
15. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat.
Caine SB; Heinrichs SC; Coffin VL; Koob GF
Brain Res; 1995 Sep; 692(1-2):47-56. PubMed ID: 8548319
[TBL] [Abstract][Full Text] [Related]
16. Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men.
Mendelson JH; Sholar MB; Goletiani N; Siegel AJ; Mello NK
Neuropsychopharmacology; 2005 Sep; 30(9):1751-63. PubMed ID: 15870834
[TBL] [Abstract][Full Text] [Related]
17. Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans.
Evans SM; Walsh SL; Levin FR; Foltin RW; Fischman MW; Bigelow GE
Drug Alcohol Depend; 2001 Nov; 64(3):271-83. PubMed ID: 11672942
[TBL] [Abstract][Full Text] [Related]
18. Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat.
Bachtell RK; Whisler K; Karanian D; Self DW
Psychopharmacology (Berl); 2005 Nov; 183(1):41-53. PubMed ID: 16163523
[TBL] [Abstract][Full Text] [Related]
19. Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers.
Rush CR; Baker RW
Exp Clin Psychopharmacol; 2001 Feb; 9(1):59-73. PubMed ID: 11519636
[TBL] [Abstract][Full Text] [Related]
20. Acute deleterious effects of cocaine on cardiac conduction, hemodynamics, and ventricular fibrillation threshold: effects of interaction with a selective dopamine D1 antagonist SCH 39166.
Kanani PM; Guse PA; Smith WM; Barnett A; Ellinwood EH
J Cardiovasc Pharmacol; 1998 Jul; 32(1):42-8. PubMed ID: 9676719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
